John A. Herrmann III
Net Worth

Last updated:

What is John A. Herrmann III net worth?

The estimated net worth of Mr. John A. Herrmann III is at least $25,749,717 as of 14 Dec 2023. He owns shares worth $36,422 as insider, has earned $18,497,845 from insider trading and has received compensation worth at least $7,215,450 in Novavax, Inc..

What is the salary of John A. Herrmann III?

Mr. John A. Herrmann III salary is $655,950 per year as Executive Vice President, Chief Legal Officer & Corporation Sec. in Novavax, Inc..

How old is John A. Herrmann III?

Mr. John A. Herrmann III is 59 years old, born in 1966.

What stocks does John A. Herrmann III currently own?

As insider, Mr. John A. Herrmann III owns shares in one company:

Company Title Shares Price per share Total value
Novavax, Inc. (NVAX) Executive Vice President, Chief Legal Officer & Corporation Sec. 3,845 $9.47 $36,422

What does Novavax, Inc. do?

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NVAX logo
NVAX
Novavax, Inc.
$9.47

John A. Herrmann III insider trading

Novavax, Inc.

Mr. John A. Herrmann III has made 36 insider trades between 2014-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 46,242 units of NVAX stock on 18 Aug 2020. As of 14 Dec 2023 he still owns at least 3,845 units of NVAX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 2,100 N/A N/A
Option
Common Stock 2,100 N/A N/A
Option
Common Stock 833 N/A N/A
Option
Restricted Stock Units 833 N/A N/A
Option
Common Stock 4,609 $6.52 $30,051
Option
Restricted Stock Units 4,609 N/A N/A
Option
Restricted Stock Units 2,100 N/A N/A
Option
Common Stock 2,100 N/A N/A
Option
Common Stock 3,973 N/A N/A
Option
Restricted Stock Units 667 N/A N/A
Option
Common Stock 667 N/A N/A
Option
Restricted Stock Units 2,000 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Common Stock 833 N/A N/A
Option
Restricted Stock Units 833 N/A N/A
Option
Common Stock 5,000 $19.08 $95,400
Sale
Common Stock 500 $140.05 $70,026
Option
Stock Option (Right to Buy) 5,000 $19.08 $95,400
Sale
Common Stock 400 $136.82 $54,728
Sale
Common Stock 100 $144.43 $14,443
Sale
Common Stock 800 $141.69 $113,350
Sale
Common Stock 997 $139.08 $138,660
Sale
Common Stock 1,003 $143.64 $144,070
Sale
Common Stock 800 $142.65 $114,117
Sale
Common Stock 400 $137.85 $55,140
Option
Common Stock 5,000 $19.08 $95,400
Option
Stock Option (Right to Buy) 5,000 $19.08 $95,400
Sale
Common Stock 5,000 $230 $1,150,000
Option
Restricted Stock Units 2,100 N/A N/A
Option
Common Stock 2,100 N/A N/A
Option
Common Stock 5,000 $19.08 $95,400
Option
Stock Option (Right to Buy) 5,000 $19.08 $95,400
Sale
Common Stock 5,000 $197.3 $986,505
Option
Common Stock 5,000 $19.08 $95,400
Option
Stock Option (Right to Buy) 5,000 $19.08 $95,400
Sale
Common Stock 5,000 $228.72 $1,143,600
Sale
Common Stock 5,000 $200 $1,000,000
Option
Stock Option (Right to Buy) 5,000 $19.08 $95,400
Option
Common Stock 5,000 $19.08 $95,400
Sale
Common Stock 5,000 $164.16 $820,815
Option
Common Stock 5,000 $19.08 $95,400
Option
Stock Option (Right to Buy) 5,000 $19.08 $95,400
Option
Restricted Stock Units 4,639 N/A N/A
Option
Common Stock 4,639 N/A N/A
Sale
Common Stock 5,000 $19.08 $95,400
Sale
Common Stock 4,900 $229.59 $1,124,986
Option
Stock Option (Right to Buy) 5,000 $19.08 $95,400
Option
Common Stock 5,000 $228.98 $1,144,905
Option
Stock Option (Right to Buy) 5,000 $19.08 $95,400
Sale
Stock Option (Right to Buy) 100 $19.08 $1,908
Option
Common Stock 2,896 $20.38 $59,029
Sale
Common Stock 2,896 $198.88 $575,948
Option
Stock Option (Right to Buy) 2,896 $20.38 $59,029
Sale
Common Stock 2,896 $213.04 $616,958
Option
Common Stock 2,896 $26.52 $76,793
Option
Common Stock 2,896 $26.52 $76,793
Option
Stock Option (Right to Buy) 2,896 $26.52 $76,793
Option
Stock Option (Right to Buy) 2,896 $26.52 $76,793
Sale
Common Stock 2,896 N/A N/A
Sale
Common Stock 2,896 $213.04 $616,958
Option
Common Stock 834 N/A N/A
Option
Restricted Stock Units 834 N/A N/A
Option
Common Stock 2,895 $26.52 $76,767
Option
Stock Option (Right to Buy) 2,895 $26.52 $76,767
Sale
Common Stock 2,895 $150.54 $435,799
Option
Stock Option (Right to Buy) 2,895 $20.38 $59,009
Sale
Common Stock 2,895 $242.18 $701,105
Sale
Common Stock 2,895 $242.18 $701,105
Option
Common Stock 2,895 $20.38 $59,009
Sale
Common Stock 2,895 N/A N/A
Option
Common Stock 2,894 $9.2 $26,625
Sale
Common Stock 2,894 $64.2 $185,801
Option
Stock Option (Right to Buy) 2,894 $11.18 $32,364
Option
Common Stock 2,895 N/A N/A
Option
Common Stock 2,895 $20.38 $59,009
Option
Stock Option (Right to Buy) 2,895 $20.38 $59,009
Sale
Common Stock 2,895 $208.83 $604,551
Sale
Common Stock 2,895 $225.72 $653,445
Option
Common Stock 15,022 $26.71 $401,238
Option
Stock Option (Right to Buy) 12,808 $26.64 $341,180
Sale
Common Stock 15,022 $241.29 $3,624,583
Option
Stock Option (Right to Buy) 12,808 N/A N/A
Sale
Common Stock 15,022 N/A N/A
Option
Common Stock 15,022 N/A N/A
Sale
Common Stock 18,029 N/A N/A
Sale
Common Stock 24,471 $112.54 $2,753,844
Sale
Common Stock 24,743 N/A N/A
Option
Common Stock 24,750 N/A N/A
Option
Stock Option (Right to Buy) 24,750 N/A N/A
Option
Common Stock 34,873 N/A N/A
Option
Restricted Stock Units 34,873 N/A N/A
Option
Restricted Stock Units 34,873 N/A N/A
Option
Common Stock 34,873 N/A N/A
Option
Stock Option (Right to Buy) 24,995 N/A N/A
Sale
Common Stock 46,242 N/A N/A
Option
Stock Option (Right to Buy) 24,995 $35.52 $887,822
Option
Common Stock 46,242 $50.63 $2,341,001
Option
Common Stock 46,242 N/A N/A
Option
Common Stock 12,961 $37.52 $486,297
Sale
Common Stock 7,499 N/A N/A
Option
Common Stock 12,961 N/A N/A
Option
Stock Option (Right to buy) 12,961 $37.52 $486,297
Option
Stock Option (Right to buy) 12,961 N/A N/A
Option
Restricted Stock Units 449 N/A N/A
Option
Common Stock 449 N/A N/A
Sale
Common Stock 3,643 N/A N/A
Option
Common Stock 4,933 N/A N/A
Option
Restricted Stock Units 4,933 N/A N/A
Purchase
Common Stock 4,960 N/A N/A
Purchase
Common Stock 2,072 N/A N/A
Sale
Common Stock 27,945 N/A N/A
Purchase
Common Stock 1,502 N/A N/A
Purchase
Common Stock 9,869 N/A N/A
Purchase
Common Stock 8,950 N/A N/A

Novavax key executives

Novavax, Inc. executives and other stock owners filed with the SEC: